Home > Healthcare > Pharmaceuticals > Finished Drug Form > Loratadine Market

Loratadine Market Share

Report ID: GMI9141
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Loratadine Market Share

The loratadine industry is fragmented in nature characterized by the presence of several pharmaceutical companies. The key market players are focused on developing improved treatments, such as longer-acting formulations and combination therapies to develop and launch new products in the market. These players are constantly engaged in growth strategies such as partnerships and collaborations, and new product launches to enhance their product portfolio.

Loratadine Market Companies

Prominent players operating in the loratadine industry include:

Bayer AG
Cadila Pharmaceuticals Limited
Cipla Ltd.
Lannett Company, Inc.
Merck KGaA
Morepen Laboratories Ltd
Perrigo Company plc
Pfizer Inc.
Sun Pharmaceutical Industries Limited
Viatris Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The loratadine market was valued at USD 140.1 million in 2023 and is anticipated to grow at 2.8% CAGR between 2024

The tablets segment in the loratadine industry accounted for USD 63.5 million in 2023, due to their convenience, ease of administration, and familiarity.

North America loratadine market is anticipated to reach USD 62 million by 2032, attributed to the high prevalence of allergies in the region and the well-established healthcare infrastructure and high awareness about allergy management.

Bayer AG, Cadila Pharmaceuticals Limited, Cipla Ltd., Lannett Company, Inc., Merck KGaA, Morepen Laboratories Ltd, Perrigo Company plc, Pfizer Inc, Sun Pharmaceutical Industries Limited and Viatris Inc.